With 2.74 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.58 million shares. The 52-week range on DNA shows that it touched its highest point at $64.40 and its lowest point at $5.26 during that stretch. It currently has a 1-year price target of $11.33. Beta for the stock currently stands at 1.19.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DNA was down-trending over the past week, with a drop of -25.27%, but this was down by -19.73% over a month. Three-month performance surged to 61.79% while six-month performance rose 23.98%. The stock lost -80.51% in the past year, while it has gained 4.79% so far this year. A look at the trailing 12-month EPS for DNA yields -12.90 with Next year EPS estimates of -2.52. For the next quarter, that number is -1.50. This implies an EPS growth rate of 43.14% for this year and 57.95% for next year.
Float and Shares Shorts:
At present, 41.37 million DNA shares are outstanding with a float of 36.50 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DNA since 5 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 2 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$9.59245 being high and -$10.6453 being low. For DNA, this leads to a yearly average estimate of -$10.08. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
